Condition: Exercise Performance · Exercise Recovery · Cognitive Function · Sponsor: Lindenwood University
The purpose of this study is to evaluate the dose-dependent effects of glucosyl-hesperidin (CITRAPEAK) supplementation on exercise performance, recovery indicators, blood flow, cognitive function, mood, sleep, and fuel utilization in recreationally active adults.
This description comes directly from the study's public registry record.
Anthony M Hagele, MS · 636-949-4785 · ahagele@lindenwood.edu
Always discuss trial participation with your own doctor first.
| Lindenwood University | Saint Charles, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06672952